160 related articles for article (PubMed ID: 38048390)
1. Comparison of the therapeutic effects of 15 mg and 30 mg initial daily prednisolone doses in patients with subacute thyroiditis: a multicenter, randomized, open-label, parallel-controlled trial.
Zeng J; Jia A; Zhang J; Gao B; Xu J; Xing Y; Jing X; Jiao Y; Wang J; Xu W; Gao L; Shang L; Xu S
Ann Med; 2023; 55(2):2288941. PubMed ID: 38048390
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the therapeutic effects of 15 mg and 30 mg initial dosage of prednisolone daily in patients with subacute thyroiditis: protocol for a multicenter, randomized, open, parallel control study.
Xu S; Jiang Y; Jia A; Zhang J; Gao B; Xu J; Jing X; Jiao Y; Wei J; Xu W; Chen R; Gao L; Shang L
Trials; 2020 May; 21(1):418. PubMed ID: 32448401
[TBL] [Abstract][Full Text] [Related]
3. Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan.
Kubota S; Nishihara E; Kudo T; Ito M; Amino N; Miyauchi A
Thyroid; 2013 Mar; 23(3):269-72. PubMed ID: 23227861
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment outcome between glucocorticoids and non-steroidal anti-inflammatory drugs in subacute thyroiditis patients-a systematic review and meta-analysis.
Yuan A; Wu J; Huang H
Front Endocrinol (Lausanne); 2024; 15():1384365. PubMed ID: 38715797
[TBL] [Abstract][Full Text] [Related]
5. Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis.
Arao T; Okada Y; Torimoto K; Kurozumi A; Narisawa M; Yamamoto S; Tanaka Y
J UOEH; 2015 Jun; 37(2):103-10. PubMed ID: 26073499
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone.
Mizukoshi T; Noguchi S; Murakami T; Futata T; Yamashita H
Intern Med; 2001 Apr; 40(4):292-5. PubMed ID: 11334386
[TBL] [Abstract][Full Text] [Related]
7. Initial treatment combined with Prunella vulgaris reduced prednisolone consumption for patients with subacute thyroiditis.
Li F; Wu Y; Chen L; Hu L; Liu X
Ann Transl Med; 2019 Feb; 7(3):45. PubMed ID: 30906749
[TBL] [Abstract][Full Text] [Related]
8. Identifying the Lowest Effective Initial Dose of Prednisolone for the Treatment of Subacute Granulomatous Thyroiditis: A Systematic Review and Meta-Analysis.
Soltani A; Nourani F; Roudsari SB; Jouybari L; Fathi M; Haghighat S; Hadavi M; Aletaha A
Curr Rev Clin Exp Pharmacol; 2022; 17(2):135-143. PubMed ID: 34636318
[TBL] [Abstract][Full Text] [Related]
9. Successful Management of Recurrent Subacute Thyroiditis by Adding Colchicine to Glucocorticoid Treatment: A Case Series Study.
Tian Z; Su Y; Zhang M; Zhang X; Guan Q
Horm Metab Res; 2020 Oct; 52(10):712-717. PubMed ID: 32365399
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-Guided Capsular Thyroid Injection Therapy With Dexamethasone and Lidocaine Mixture for Subacute Thyroiditis: A Single-Center Study.
Huo J; Chen C; Gao D; Yang L; Qu R; Jiang H; Chen X; Guo Y; Zhu S; Ou D; Zhao L
J Ultrasound Med; 2023 Feb; 42(3):613-621. PubMed ID: 36056908
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis.
Sato J; Uchida T; Komiya K; Goto H; Takeno K; Suzuki R; Honda A; Himuro M; Watada H
Endocrine; 2017 Jan; 55(1):209-214. PubMed ID: 27688010
[TBL] [Abstract][Full Text] [Related]
12. An Evaluation of the Results of the Steroid and Non-steroidal Anti-inflammatory Drug Treatments in Subacute Thyroiditis in relation to Persistent Hypothyroidism and Recurrence.
Sencar ME; Calapkulu M; Sakiz D; Hepsen S; Kus A; Akhanli P; Unsal IO; Kizilgul M; Ucan B; Ozbek M; Cakal E
Sci Rep; 2019 Nov; 9(1):16899. PubMed ID: 31729433
[TBL] [Abstract][Full Text] [Related]
13. Long-term Outcome of Subacute Thyroiditis.
Görges J; Ulrich J; Keck C; Müller-Wieland D; Diederich S; Janssen OE
Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):703-708. PubMed ID: 31546269
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Versus 6-Week Prednisone In The Treatment Of Subacute Thyroiditis: A Randomized Controlled Trial.
Duan L; Feng X; Zhang R; Tan X; Xiang X; Shen R; Zheng H
Endocr Pract; 2020 Aug; 26(8):900-908. PubMed ID: 33471681
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of two different dosages of prednisone for treatment of subacute thyroiditis: a single-centre, prospective, randomized, open-label, non-inferiority trial.
Xu Y; Liu S; Zeng X; Wu Q; Chen Y; He C; Zhai Q; Zhang B; Gao J
Endokrynol Pol; 2023; 74(2):168-175. PubMed ID: 37155300
[TBL] [Abstract][Full Text] [Related]
16. Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis.
Nishihara E; Amino N; Ohye H; Ota H; Ito M; Kubota S; Fukata S; Miyauchi A
J Endocrinol Invest; 2009 Jan; 32(1):33-6. PubMed ID: 19337012
[TBL] [Abstract][Full Text] [Related]
17. THE USE OF LOW DOSE PREDNISOLONE IN PATIENTS WITH SUBACUTE THYROIDITIS AND ITS EFFECT ON IMPAIRED LIFE AND SLEEP QUALITY.
Saydam BO; Adiyaman SC; Demir T; Comlekci A; Yener S
Acta Endocrinol (Buchar); 2022; 18(1):64-73. PubMed ID: 35975250
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Subacute Thyroiditis Recurrence: A Systematic Review and Meta-Analysis of Cohort Studies.
Zhang J; Ding G; Li J; Li X; Ding L; Li X; Yang S; Tang F
Front Endocrinol (Lausanne); 2021; 12():783439. PubMed ID: 35002966
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Two-Years Prospective Follow-Up Study of Subacute Thyroiditis.
Zhao N; Wang S; Cui XJ; Huang MS; Wang SW; Li YG; Zhao L; Wan WN; Li YS; Shan ZY; Teng WP
Front Endocrinol (Lausanne); 2020; 11():47. PubMed ID: 32184756
[No Abstract] [Full Text] [Related]
[Next] [New Search]
